Medscape is available in 5 Language Editions – Choose your Edition here.


Fetal Alcohol Syndrome

  • Author: Keith K Vaux, MD; Chief Editor: Ted Rosenkrantz, MD  more...
Updated: Jan 16, 2015


Adverse fetal, neonatal, and pediatric effects occur with maternal alcohol consumption during pregnancy. The diagnosis of fetal alcohol syndrome (FAS) is based on findings in the following 3 areas: (1) characteristic facial anomalies (see image below), (2) growth retardation (intrauterine growth restriction and failure to have catch-up growth), and (3) CNS involvement (cognitive impairment, learning disabilities, or behavioral abnormalities).

Facial characteristics of a child with fetal alcoh Facial characteristics of a child with fetal alcohol syndrome.

Prenatal exposure to alcohol is associated with a variable spectrum of effects referred to as fetal alcohol spectrum disorders (FASD), with fetal alcohol syndrome at the most severe end of that spectrum. Children with fetal alcohol syndrome disorder may have clinically significant CNS involvement but few or no characteristic physical features.

Lemoine et al first described the pattern of malformation associated with heavy prenatal alcohol exposure in France in 1968, and Jones and Smith first described it in the United States in 1973.[1] Prenatal alcohol exposure is of substantial public health concern for the following reasons: (1) FAS is the leading known cause of mental retardation, (2) fetal alcohol syndrome or fetal alcohol syndrome disorder is associated with persistent physical and neurodevelopmental abnormalities,[2] and (3) fetal alcohol syndrome disorder crosses all socioeconomic groups and affects all races and ethnicities. The costs for 1 child with fetal alcohol syndrome are estimated to be $2 million over a lifetime, and costs of fetal alcohol syndrome to the American taxpayer are more than $321 million each year.



Alcohol crosses the placenta and rapidly reaches the fetus. Extensive studies have demonstrated equivalent fetal and maternal alcohol concentrations, suggesting an unimpeded bidirectional movement of alcohol between the 2 compartments. The fetus appears to depend on maternal hepatic detoxification because the activity of alcohol dehydrogenase (ADH) in the fetal liver is less than 10% of that observed in the adult liver. Furthermore, the amniotic fluid acts as a reservoir for alcohol, prolonging fetal exposure.

The mechanism for the spectrum of adverse effects on virtually all organ systems of the developing fetus is unknown. Ethanol and its metabolite acetaldehyde can alter fetal development by disrupting cellular differentiation and growth, disrupting DNA and protein synthesis and inhibiting cell migration. Both ethanol and acetaldehyde modify the intermediary metabolism of carbohydrates, proteins, and fats. Both also decrease the transfer of amino acids, glucose, folic acid, zinc, and other nutrients across the placental barrier, indirectly affecting fetal growth due to intrauterine nutrient deprivation. Elevated levels of erythropoietin in the cord blood of newborns exposed to alcohol are reported and suggest a state of chronic fetal hypoxia.

Studies have shown that prenatal alcohol exposure affects the hypothalamic-pituitary-adrenal (HPA) axis as well as alters basal and poststress cortisol levels.[3] In a Canadian study involving 26 children (aged 6-14 y) and 32 control children, Keiver et al found significantly elevated cortisol levels in the afternoon and at bedtime in those with known high prenatal exposure to alcohol (alcohol exposure rank 4) relative to those with low/unknown levels of prenatal alcohol exposure (alcohol exposure rank 3) and the control group. The investigators suggest these findings provide evidence for HPA dysregulation due to chronic fetal alcohol exposure, which may lead to long-term psychologic and medical morbidity.[3]




United States

Although careful comprehensive studies have not been performed and though passive surveillance systems are inadequate to measure the incidence of fetal alcohol syndrome or fetal alcohol syndrome disorder, the incidence of fetal alcohol syndrome in the United States is estimated to be 1-2 cases per 1000 live births. The incidence is related to the population studied, with highest incidence reported in areas where heavy drinking during pregnancy is common and where attention to diagnosis is greatest.

To date, no comprehensive population-based study with careful and standardized diagnostic methods applied to a large, representative sample of children has been performed. Likewise, the incidence of the broad spectrum of fetal alcohol syndrome disorder has not been well studied. However, data in one sample demonstrated that approximately 1 in 100 children have alcohol-related effects.

Among the subset of high-risk pregnant drinkers, estimated incidences of fetal alcohol syndrome differ because of variable definitions of heavy drinking and inconsistent methods of diagnosis. Therefore, rates range from 4% to as much as 44%.


Estimated rates of fetal alcohol syndrome in international settings are sparse in the literature. They are based on variable definitions and methods of ascertainment and range from 1 in 1000 to less than 1 in 10,000 live births. However, in some extremely high-risk areas, such as selected communities in South Africa where binge drinking in pregnancy is relatively common, careful in-school assessments have shown that rates of fetal alcohol syndrome may be as high as 4-5% of all children in the normal first grade in school.


Adverse effects on the outcome of pregnancy, in addition to fetal alcohol syndrome disorder, have been noted with chronic or heavy alcohol use. These effects include an increased risk for spontaneous abortion, placental abruption, preterm delivery, amnionitis, stillbirth, and sudden infant death syndrome.

Commonly associated factors, such as maternal tobacco or other substance abuse, low socioeconomic status, and poor nutrition, complicate the morbidity and mortality associated with prenatal alcohol exposure.


Regardless of race or ethnicity, fetal alcohol syndrome and fetal alcohol syndrome disorder occur in women who drink heavily during pregnancy. Rates of fetal alcohol syndrome appear to be highest among groups of low socioeconomic status. What is unknown is how these findings are related to a high prevalence of risky drinking in some populations; compromised nutritional status or general health; and, therefore, reduced resiliency to the effects of alcohol, possible genetic susceptibility, or a combination of these and other factors.

Contributor Information and Disclosures

Keith K Vaux, MD Professor of Medicine, Clinical Chief and Division Director, Division of Medical Genetics, Department of Medicine, University of California, San Diego, School of Medicine; Director, Rare Disease Program, Rady Children's Hospital San Diego and UC San Diego

Keith K Vaux, MD is a member of the following medical societies: American Academy of Pediatrics, Western Society for Pediatric Research

Disclosure: Nothing to disclose.


Christina Chambers, MPH, PhD Associate Professor of Pediatrics and Family and Preventive Medicine, University of California at San Diego; Assistant Professor, Graduate School of Public Health, San Diego State University

Christina Chambers, MPH, PhD is a member of the following medical societies: Society for Epidemiologic Research, Teratology Society, Research Society on Alcoholism, International Society for Pharmacoepidemiology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Arun K Pramanik, MD, MBBS Professor of Pediatrics, Louisiana State University Health Sciences Center

Arun K Pramanik, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, National Perinatal Association, Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Eastern Society for Pediatric Research, American Medical Association, Connecticut State Medical Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

Oussama Itani, MD, FAAP, FACN Clinical Associate Professor of Pediatrics and Human Development, Michigan State University; Medical Director, Department of Neonatology, Borgess Medical Center

Oussama Itani, MD, FAAP, FACN is a member of the following medical societies: American Academy of Pediatrics, American Association for Physician Leadership, American Heart Association, American College of Nutrition

Disclosure: Nothing to disclose.


The authors gratefully acknowledge the contributions of Christine D Dittmer, MD, and Sarah L Lentz-Kapua, MD, to the writing and development of this article.

  1. Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973 Nov 3. 2(7836):999-1001. [Medline].

  2. Gray R, Mukherjee RA, Rutter M. Alcohol consumption during pregnancy and its effects on neurodevelopment: what is known and what remains uncertain. Addiction. 2009 Aug. 104(8):1270-3. [Medline].

  3. Keiver K, Bertram CP, Orr AP, Clarren S. Salivary cortisol levels are elevated in the afternoon and at bedtime in children with prenatal alcohol exposure. Alcohol. 2014 Dec 13. [Medline].

  4. Mattson SN, Roesch SC, Glass L, Deweese BN, Coles CD, Kable JA, et al. Further Development of a Neurobehavioral Profile of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2012 Sep 13. [Medline].

  5. Sujay NK, Jones M, Whittle E, Murphy H, Auth MK. Severe gastrooesophageal reflux disease associated with foetal alcohol syndrome. Case Rep Pediatr. 2012. 2012:509253. [Medline]. [Full Text].

  6. Colin Carter R, Jacobson JL, Molteno CD, Jiang H, Meintjes EM, Jacobson SW, et al. Effects of Heavy Prenatal Alcohol Exposure and Iron Deficiency Anemia on Child Growth and Body Composition through Age 9 Years. Alcohol Clin Exp Res. 2012 Aug 15. [Medline].

  7. Kuehn D, Aros S, Cassorla F, Avaria M, Unanue N, Henriquez C, et al. A prospective cohort study of the prevalence of growth, facial, and central nervous system abnormalities in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res. 2012 Oct. 36(10):1811-9. [Medline].

  8. Bonthius DJ, Tzouras G, Karacay B, Mahoney J, Hutton A, McKim R. Deficiency of neuronal nitric oxide synthase (nNOS) worsens alcohol-induced microencephaly and neuronal loss in developing mice. Brain Res Dev Brain Res. 2002 Sep 20. 138(1):45-59. [Medline].

  9. Astley SJ, Aylward EH, Olson HC, et al. Magnetic Resonance Imaging Outcomes From a Comprehensive Magnetic Resonance Study of Children With Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2009 Jul 1. [Medline].

  10. Karunamuni G, Gu S, Doughman YQ, et al. Using optical coherence tomography to rapidly phenotype and quantify congenital heart defects associated with prenatal alcohol exposure. Dev Dyn. 2014 Dec 27. [Medline].

  11. Taylor PA, Jacobson SW, van der Kouwe A, et al. A DTI-based tractography study of effects on brain structure associated with prenatal alcohol exposure in newborns. Hum Brain Mapp. 2015 Jan. 36(1):170-86. [Medline].

  12. Rangmar J, Hjern A, Vinnerljung B, Strömland K, Aronson M, Fahlke C. Psychosocial outcomes of fetal alcohol syndrome in adulthood. Pediatrics. 2015 Jan. 135(1):e52-8. [Medline].

  13. Abel EL. "Moderate" drinking during pregnancy: cause for concern?. Clin Chim Acta. 1996 Mar 15. 246(1-2):149-54. [Medline].

  14. Abel EL. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 1995 Jul-Aug. 17(4):437-43. [Medline].

  15. Abel EL. Fetal alcohol syndrome: the American Paradox. Alcohol Alcohol. 1998 May-Jun. 33(3):195-201. [Medline].

  16. [Guideline] Bertrand J, Floyd LL, Weber MK. Guidelines for identifying and referring persons with fetal alcohol syndrome. MMWR Recomm Rep. 2005 Oct 28. 54:1-14. [Medline].

  17. Carmichael Olson H, Burgess DM, Streissguth AP. Fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE): A lifespan view, with implications for intervention. Zero to Three/National Center for Clinical Infant Programs. 13(1):1992: 24-9.

  18. Clark CM, Li D, Conry J, et al. Structural and functional brain integrity of fetal alcohol syndrome in nonretarded cases. Pediatrics. 2000 May. 105(5):1096-9. [Medline].

  19. Day NL, Richardson GA. Prenatal alcohol exposure: a continuum of effects. Semin Perinatol. 1991 Aug. 15(4):271-9. [Medline].

  20. Flandermeyer A. The drug exposed neonate. Kenner C, ed. Comprehensive Neonatal Nursing: A Physiological Perspective. Philadelphia, PA: WB Saunders; 1993. 997-1033.

  21. Forrest F, Florey CD, Taylor D, McPherson F, Young JA. Reported social alcohol consumption during pregnancy and infants' development at 18 months. BMJ. 1991 Jul 6. 303(6793):22-6. [Medline].

  22. Hoyme HE, May PA, Kalberg WO, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 institute of medicine criteria. Pediatrics. 2005 Jan. 115(1):39-47. [Medline].

  23. Iyasu S, Randall LL, Welty TK, et al. Risk factors for sudden infant death syndrome among northern plains Indians. JAMA. 2002 Dec 4. 288(21):2717-23. [Medline].

  24. Jacobson SW, Chiodo LM, Sokol RJ, Jacobson JL. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics. 2002 May. 109(5):815-25. [Medline].

  25. Kavale KA, Karge BD. Fetal alcohol syndrome: A behavioral teratology. The Exceptional Child. Columbus, OH: Charles E. Merrill; 1986. 1986: 4-16.

  26. Levy M, Koren G. Clinical toxicology of the neonate. Semin Perinatol. 1992 Feb. 16(1):63-75. [Medline].

  27. May PA, Brooke L, Gossage JP, et al. Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. Am J Public Health. 2000 Dec. 90(12):1905-12. [Medline].

  28. May PA, Gossage JP, White-Country M, et al. Alcohol consumption and other maternal risk factors for fetal alcohol syndrome among three distinct samples of women before, during, and after pregnancy: the risk is relative. Am J Med Genet C Semin Med Genet. 2004 May 15. 127(1):10-20. [Medline].

  29. Phelps L, Grabowski J. Fetal alcohol syndrome: Diagnostic features and psychoeducational risk factors. School Psychol Q. 1992. 7(2):112-28.

  30. Russell M. Clinical implications of recent research on the fetal alcohol syndrome. Bull N Y Acad Med. 1991 May-Jun. 67(3):207-22. [Medline].

  31. Russell M, Czarnecki DM, Cowan R, et al. Measures of maternal alcohol use as predictors of development in early childhood. Alcohol Clin Exp Res. 1991 Dec. 15(6):991-1000. [Medline].

  32. Sampson PD, Streissguth AP, Bookstein FL. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997 Nov. 56(5):317-26. [Medline].

  33. Shaywitz SE, Cohen DJ, Shaywitz BA. Behavior and learning difficulties in children of normal intelligence born to alcoholic mothers. J Pediatr. 1980 Jun. 96(6):978-82. [Medline].

  34. Sommers M. Alcohol intoxication and multiple trauma: A catastrophic combination. Med Surg Nurs Q. 1992. 1:110-21.

  35. Spadoni AD, McGee CL, Fryer SL, Riley EP. Neuroimaging and fetal alcohol spectrum disorders. Neurosci Biobehav Rev. 2007. 31(2):239-45. [Medline].

  36. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. National Academy Press; 1996.

  37. Streissguth A, LaDue R. Psychological and behavioral effects in children prenatally exposed to alcohol. Alcohol Health Res World. 1985. 10:6-12.

  38. Streissguth AP, Barr HM, Sampson PD, Bookstein FL. Prenatal alcohol and offspring development: the first fourteen years. Drug Alcohol Depend. 1994 Oct. 36(2):89-99. [Medline].

  39. Taybi H. Handbook of Syndromes and Metabolic Disorders: Radiologic and Clinical Manifestations. Philadelphia, PA: Mosby-Year Book; 1998. 71-2.

  40. Warren KR, Li TK. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol. 2005 Apr. 73(4):195-203. [Medline].

  41. West JR, Goodlett CR, Brandt JP. New approaches to research on the long-term consequences of prenatal exposure to alcohol. Alcohol Clin Exp Res. 1990 Oct. 14(5):684-9. [Medline].

Facial characteristics of a child with fetal alcohol syndrome.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.